AG

Alessandro Massimo Gianni

CU Columbia University: 2 patents #655 of 2,492Top 30%
FT Fondazione Irccs Istituto Nazionale Dei Tumori: 1 patents #5 of 34Top 15%
GS Gentium S.R.L.: 1 patents #5 of 9Top 60%
SA Sandoz Ag: 1 patents #497 of 1,103Top 50%
Overall (All Time): #976,150 of 4,157,543Top 25%
5
Patents All Time

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10813995 Bispecific antibody binding TRAIL-R2 and CD3 Mariangela Figini, Alessandro Satta, Massimo Di Nicola 2020-10-27
9782429 Formulation having mobilizing activity Laura Ferro, Roberto Porta, Massimo Iacobelli, Carmelo Carlo Stella 2017-10-10
6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs Riccardo Dalla-Favera 2001-07-31
5888820 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector Riccardo Dalla-Favera 1999-03-30
5649904 Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both 1997-07-22